Appleton Partners Inc Abbott Laboratories Transaction History

Appleton Partners Inc

  • $1.36 Billion
  • Q3 2024

A detailed history of Appleton Partners Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Appleton Partners Inc holds 13,886 shares of ABT stock, worth $1.57 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,886
Previous 14,692 5.49%
Holding current value
$1.57 Million
Previous $1.53 Million 3.67%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
SELL
$100.07 - $118.13 $80,656 - $95,212
-806 Reduced 5.49%
13,886 $1.58 Million
Q2 2024

Jul 02, 2024
SELL
$100.73 - $112.44 $234,700 - $261,985
-2,330 Reduced 13.69%
14,692 $1.53 Million
Q1 2024

Apr 01, 2024
SELL
$109.52 - $120.96 $109,410 - $120,839
-999 Reduced 5.54%
17,022 $1.94 Million
Q4 2023

Jan 02, 2024
SELL
$90.19 - $110.4 $47,169 - $57,739
-523 Reduced 2.82%
18,021 $1.98 Million
Q3 2023

Oct 03, 2023
SELL
$95.53 - $114.62 $201,759 - $242,077
-2,112 Reduced 10.22%
18,544 $1.8 Million
Q2 2023

Jul 10, 2023
BUY
$100.78 - $112.29 $31,040 - $34,585
308 Added 1.51%
20,656 $2.25 Million
Q1 2023

Apr 10, 2023
BUY
$96.86 - $114.01 $72,935 - $85,849
753 Added 3.84%
20,348 $2.06 Million
Q4 2022

Jan 19, 2023
BUY
$95.06 - $111.52 $3,136 - $3,680
33 Added 0.17%
19,595 $2.15 Million
Q3 2022

Oct 27, 2022
SELL
$96.76 - $112.03 $48,186 - $55,790
-498 Reduced 2.48%
19,562 $1.89 Million
Q2 2022

Jul 08, 2022
SELL
$102.07 - $123.37 $20,822 - $25,167
-204 Reduced 1.01%
20,060 $2.18 Million
Q1 2022

Apr 05, 2022
SELL
$114.02 - $139.04 $87,339 - $106,504
-766 Reduced 3.64%
20,264 $2.4 Million
Q4 2021

Feb 03, 2022
BUY
$115.53 - $141.46 $55,223 - $67,617
478 Added 2.33%
21,030 $2.96 Million
Q3 2021

Oct 14, 2021
SELL
$116.66 - $129.06 $135,558 - $149,967
-1,162 Reduced 5.35%
20,552 $2.43 Million
Q2 2021

Jul 07, 2021
BUY
$105.79 - $124.53 $193,278 - $227,516
1,827 Added 9.19%
21,714 $2.52 Million
Q1 2021

Apr 19, 2021
SELL
$108.84 - $128.23 $66,065 - $77,835
-607 Reduced 2.96%
19,887 $2.38 Million
Q4 2020

Jan 19, 2021
SELL
$105.0 - $114.42 $165,480 - $180,325
-1,576 Reduced 7.14%
20,494 $2.24 Million
Q3 2020

Oct 14, 2020
SELL
$91.64 - $111.29 $55,075 - $66,885
-601 Reduced 2.65%
22,070 $2.4 Million
Q2 2020

Aug 14, 2020
BUY
$76.57 - $98.0 $1,990 - $2,548
26 Added 0.11%
22,671 $2.07 Million
Q1 2020

May 04, 2020
SELL
$62.82 - $91.86 $110,688 - $161,857
-1,762 Reduced 7.22%
22,645 $1.79 Million
Q4 2019

Jan 13, 2020
SELL
$78.51 - $87.4 $14,288 - $15,906
-182 Reduced 0.74%
24,407 $2.12 Million
Q3 2019

Nov 04, 2019
BUY
$81.84 - $88.74 $10,066 - $10,915
123 Added 0.5%
24,589 $2.06 Million
Q2 2019

Jul 25, 2019
BUY
$72.88 - $85.0 $37,387 - $43,605
513 Added 2.14%
24,466 $2.06 Million
Q1 2019

Apr 17, 2019
BUY
$66.22 - $80.06 $230,313 - $278,448
3,478 Added 16.99%
23,953 $1.92 Million
Q4 2018

Jan 17, 2019
BUY
$65.56 - $74.27 $37,893 - $42,928
578 Added 2.9%
20,475 $1.48 Million
Q3 2018

Oct 09, 2018
SELL
$60.81 - $73.36 $2,614 - $3,154
-43 Reduced 0.22%
19,897 $1.46 Million
Q2 2018

Aug 08, 2018
SELL
$57.57 - $63.54 $30,454 - $33,612
-529 Reduced 2.58%
19,940 $1.22 Million
Q1 2018

Apr 11, 2018
BUY
$56.27 - $63.62 $20,426 - $23,094
363 Added 1.81%
20,469 $1.23 Million
Q4 2017

Jan 12, 2018
SELL
$53.68 - $57.47 $36,234 - $38,792
-675 Reduced 3.25%
20,106 $1.15 Million
Q3 2017

Oct 12, 2017
BUY
$48.06 - $53.64 $998,734 - $1.11 Million
20,781
20,781 $1.11 Million

Others Institutions Holding ABT

# of Institutions
3,167
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email